The focus of this webinar by expert speaker Will Woodlee will be on the U.S. Food and Drug Administration’s (FDA’s) rules for marketing personal care and beauty products like cosmetics and avoiding getting charged of unapproved drug promotion. Will would be explaining the differences in the drug and cosmetic categories, which includes the regulatory requirements which make marketing drugs a lot more costly and burdensome.
You will also get to know about how the regulatory status is determined by the FDA – cosmetic verses drugs – of personal care and beauty products under the “intended use” doctrine. After analysing crucial FDA positions as well as enforcement trends and precedents, you will be provided with practical tips for marketing these products as cosmetics consistent with current FDA policies.
You will gain a detailed understanding of:
Who Should Attend
Will Woodlee is a partner in the Washington, DC, law firm of Kleinfeld, Kaplan & Becker, LLP. His practice focuses primarily on counseling and advocating on behalf of food, dietary supplement, cosmetic, pharmaceutical, medical device, tobacco, and consumer product companies on regulatory and advertising law matters. W... More info